Katharina H C Roese, Sarah Ibrahim, Lauren A Cooper, Afnan S Yahya, Dongjae Kang, Nikhil R Tirupathigari, Koby A J LaRose, Karen L Houseknecht, Deborah J Barlow, Kristin M Burkholder
{"title":"Pyrogallol Exhibits Antimicrobial Adjuvant Properties Against Staphylococcus aureus and Staphylococcus epidermidis.","authors":"Katharina H C Roese, Sarah Ibrahim, Lauren A Cooper, Afnan S Yahya, Dongjae Kang, Nikhil R Tirupathigari, Koby A J LaRose, Karen L Houseknecht, Deborah J Barlow, Kristin M Burkholder","doi":"10.1093/jambio/lxaf189","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To investigate the effect of pyrogallol as an antimicrobial adjuvant against staphylococci.</p><p><strong>Methods and results: </strong>We tested the effect of pyrogallol on the susceptibility of four strains of S. aureus and S. epidermidis to antibiotics. In minimum inhibitory concentration (MIC) assays, pyrogallol significantly enhanced the anti-staphylococcal efficacy of linezolid against all strains and increased cefoxitin and oxacillin activity against individual strains. Given pyrogallol's prooxidant properties, we compared its effect on linezolid activity in wild-type and catalase-deficient S. aureus. Catalase-deficient bacteria exhibited greater linezolid sensitivity than WT in presence of pyrogallol. Antibiotic accumulation assays revealed greater intracellular linezolid concentration in S. aureus treated with pyrogallol compared to bacteria treated with linezolid alone.</p><p><strong>Conclusions: </strong>Pyrogallol potentiates linezolid-mediated killing of staphylococci in a manner involving oxidative stress and intra-bacterial antibiotic accumulation. Pyrogallol may have utility as an anti-staphylococcal antimicrobial adjuvant.</p>","PeriodicalId":15036,"journal":{"name":"Journal of Applied Microbiology","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/jambio/lxaf189","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To investigate the effect of pyrogallol as an antimicrobial adjuvant against staphylococci.
Methods and results: We tested the effect of pyrogallol on the susceptibility of four strains of S. aureus and S. epidermidis to antibiotics. In minimum inhibitory concentration (MIC) assays, pyrogallol significantly enhanced the anti-staphylococcal efficacy of linezolid against all strains and increased cefoxitin and oxacillin activity against individual strains. Given pyrogallol's prooxidant properties, we compared its effect on linezolid activity in wild-type and catalase-deficient S. aureus. Catalase-deficient bacteria exhibited greater linezolid sensitivity than WT in presence of pyrogallol. Antibiotic accumulation assays revealed greater intracellular linezolid concentration in S. aureus treated with pyrogallol compared to bacteria treated with linezolid alone.
Conclusions: Pyrogallol potentiates linezolid-mediated killing of staphylococci in a manner involving oxidative stress and intra-bacterial antibiotic accumulation. Pyrogallol may have utility as an anti-staphylococcal antimicrobial adjuvant.
期刊介绍:
Journal of & Letters in Applied Microbiology are two of the flagship research journals of the Society for Applied Microbiology (SfAM). For more than 75 years they have been publishing top quality research and reviews in the broad field of applied microbiology. The journals are provided to all SfAM members as well as having a global online readership totalling more than 500,000 downloads per year in more than 200 countries. Submitting authors can expect fast decision and publication times, averaging 33 days to first decision and 34 days from acceptance to online publication. There are no page charges.